Drug Research
Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance
Samsung Biologics announced a new agreement with Bristol Myers Squibb for large-scale manufacturing of a Bristol Myers Squibb commercial antibody cancer drug substance.
Bristol Myers...
News
Pistoia Alliance Enables Instant, Secure Transfer of Analytical Methods and Results Data Ahead of FDA Guidance
The Pistoia Alliance has announced an industry first for its Methods Hub project; the cloud-based collaborative tool now enables the instant transfer and overlaying...
News
ST Pharm breaks ground on 2nd oligonucleotide manufacturing plant
ST Pharm said it has taken its first step towards becoming the global leader in the oligonucleotide contract development and manufacturing organization (CDMO) domain...
Drug Research
As Lonza CEO departs, Catalent scoops up rival CDMO’s bioscience business head to lead biologics
Mere hours after it surfaced that Lonza’s CEO, Pierre-Alain Ruffieux, will step down, the Swiss CDMO has lost another major executive. And this time,...
Drug Research
Drug Diversion Detection Through AI Effective In Hospitals
Research conducted by Wolters Kluwer, an information and software company, suggests that artificial intelligence (AI) can potentially reduce drug diversion in hospitals. The study...
News
Rentschler Biopharma’s ATMP Facility in UK Receives MHRA Approval
Rentschler Biopharma SE, a leading global contract development and manufacturing organisation (CDMO) forbiopharmaceuticals, including advanced therapy medicinal products (ATMPs), has received the cGMP Manufacturing...
Drug Research
Sygnature Discovery’s hit finding expertise in high demand as cardiac biotech, River BioMedics, receives an additional €2M seed investment
Sygnature Discovery (Sygnature) is delighted to announce that its customer, River BioMedics, has raised an additional €2M in seed funding to continue its life-saving...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read